Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference of...
News
ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma
In patients with newly diagnosed multiple myeloma (MM) who are ineligible for high-dose chemotherapy and transplantation, adding daratumumab to...
Cancer drug funding welcomed
Mark Wellington cherished the final years he spent with his wife after she was diagnosed with multiple myeloma. Now he wants Pharmac to make good on...
Myeloma NZ calls on Pharmac to make good on access deal
Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer treatment lenalidomide (Revlimid)...
Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer
Media Release In a move welcomed by patient advocacy group Myeloma New Zealand, drug buying agency Pharmac has proposed to widen access to blood...
Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma
Results from a new study at Hutchinson Cancer Research Cancer in Seattle suggests that chimeric antigen receptor (CAR) T-cell therapy can be further...
Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’
The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent Cancer Control Agency was formally opened on Tuesday....
Major developments in multiple myeloma to be presented at ASH
Starting Saturday, December 7, HemOnc Today will be onsite in Orlando at the ASH Annual Meeting and Exposition, bringing the latest in important,...
Myeloma Medicines Applications: The status of medicines applications for myeloma currently with Pharmac
A summary of events and the status of medicines applications for myeloma currently with Pharmac  Tania Crosbie Special Projects Manager, Myeloma...
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
The objective of the study was to assess racial disparities in the treatment and outcomes among white, African American, and Hispanic patients with...
Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget
There are issues involving Pharmac and how they fund medicines - Pharmac does not adopt international guidelines; it does not set a timeframe by...
FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma
The U.S. Food and Drug Administration (FDA) approved the quadruplet regimen consisting of daratumumab, bortezomib, thalidomide, and dexamethasone to...